nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C19—epilepsy syndrome	0.176	0.574	CbGaD
Bicalutamide—CYP2D6—epilepsy syndrome	0.131	0.426	CbGaD
Bicalutamide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0243	0.0516	CbGbCtD
Bicalutamide—CYP2C19—Felbamate—epilepsy syndrome	0.0226	0.048	CbGbCtD
Bicalutamide—CYP2C19—Trimethadione—epilepsy syndrome	0.0226	0.048	CbGbCtD
Bicalutamide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0212	0.0451	CbGbCtD
Bicalutamide—CYP2C9—Trimethadione—epilepsy syndrome	0.0188	0.0399	CbGbCtD
Bicalutamide—CYP2C19—Clobazam—epilepsy syndrome	0.0184	0.0391	CbGbCtD
Bicalutamide—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0176	0.0375	CbGbCtD
Bicalutamide—CYP2C19—Carbamazepine—epilepsy syndrome	0.0152	0.0324	CbGbCtD
Bicalutamide—CYP2C19—Primidone—epilepsy syndrome	0.0142	0.0302	CbGbCtD
Bicalutamide—CYP2C19—Phenytoin—epilepsy syndrome	0.0137	0.0291	CbGbCtD
Bicalutamide—CYP2C19—Propofol—epilepsy syndrome	0.0128	0.0271	CbGbCtD
Bicalutamide—CYP2C9—Carbamazepine—epilepsy syndrome	0.0127	0.0269	CbGbCtD
Bicalutamide—CYP2C19—Phenobarbital—epilepsy syndrome	0.0122	0.0259	CbGbCtD
Bicalutamide—CYP2C9—Primidone—epilepsy syndrome	0.0118	0.0251	CbGbCtD
Bicalutamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0117	0.0249	CbGbCtD
Bicalutamide—CYP2C19—Diazepam—epilepsy syndrome	0.0116	0.0245	CbGbCtD
Bicalutamide—CYP2C9—Phenytoin—epilepsy syndrome	0.0114	0.0242	CbGbCtD
Bicalutamide—CYP2C19—Zonisamide—epilepsy syndrome	0.0113	0.024	CbGbCtD
Bicalutamide—CYP3A4—Felbamate—epilepsy syndrome	0.0109	0.0232	CbGbCtD
Bicalutamide—CYP3A4—Trimethadione—epilepsy syndrome	0.0109	0.0232	CbGbCtD
Bicalutamide—CYP2C9—Propofol—epilepsy syndrome	0.0106	0.0225	CbGbCtD
Bicalutamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0103	0.0218	CbGbCtD
Bicalutamide—CYP2C9—Phenobarbital—epilepsy syndrome	0.0101	0.0215	CbGbCtD
Bicalutamide—CYP2D6—Propofol—epilepsy syndrome	0.00969	0.0206	CbGbCtD
Bicalutamide—CYP2C9—Diazepam—epilepsy syndrome	0.00961	0.0204	CbGbCtD
Bicalutamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00928	0.0197	CbGbCtD
Bicalutamide—CYP2C19—Valproic Acid—epilepsy syndrome	0.00911	0.0194	CbGbCtD
Bicalutamide—CYP3A4—Clobazam—epilepsy syndrome	0.00889	0.0189	CbGbCtD
Bicalutamide—CYP2C19—Topiramate—epilepsy syndrome	0.00822	0.0175	CbGbCtD
Bicalutamide—CYP2C9—Valproic Acid—epilepsy syndrome	0.00757	0.0161	CbGbCtD
Bicalutamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00756	0.0161	CbGbCtD
Bicalutamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00737	0.0157	CbGbCtD
Bicalutamide—CYP3A4—Primidone—epilepsy syndrome	0.00688	0.0146	CbGbCtD
Bicalutamide—CYP3A4—Phenytoin—epilepsy syndrome	0.00661	0.014	CbGbCtD
Bicalutamide—CYP3A4—Propofol—epilepsy syndrome	0.00616	0.0131	CbGbCtD
Bicalutamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00589	0.0125	CbGbCtD
Bicalutamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00589	0.0125	CbGbCtD
Bicalutamide—CYP3A4—Midazolam—epilepsy syndrome	0.00581	0.0123	CbGbCtD
Bicalutamide—CYP3A4—Diazepam—epilepsy syndrome	0.00559	0.0119	CbGbCtD
Bicalutamide—CYP3A4—Zonisamide—epilepsy syndrome	0.00545	0.0116	CbGbCtD
Bicalutamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0044	0.00935	CbGbCtD
Bicalutamide—CYP3A4—Topiramate—epilepsy syndrome	0.00397	0.00844	CbGbCtD
Bicalutamide—Enzalutamide—CYP2C19—epilepsy syndrome	0.000885	0.354	CrCbGaD
Bicalutamide—Enzalutamide—CYP2D6—epilepsy syndrome	0.000656	0.262	CrCbGaD
Bicalutamide—Enzalutamide—ALB—epilepsy syndrome	0.000491	0.196	CrCbGaD
Bicalutamide—Enzalutamide—ABCB1—epilepsy syndrome	0.000469	0.187	CrCbGaD
Bicalutamide—Diarrhoea—Zonisamide—epilepsy syndrome	4.48e-05	0.000228	CcSEcCtD
Bicalutamide—Pharyngitis—Topiramate—epilepsy syndrome	4.48e-05	0.000228	CcSEcCtD
Bicalutamide—Loss of consciousness—Pregabalin—epilepsy syndrome	4.47e-05	0.000228	CcSEcCtD
Bicalutamide—Asthenia—Oxcarbazepine—epilepsy syndrome	4.47e-05	0.000228	CcSEcCtD
Bicalutamide—Pruritus—Clonazepam—epilepsy syndrome	4.47e-05	0.000227	CcSEcCtD
Bicalutamide—Vomiting—Vigabatrin—epilepsy syndrome	4.46e-05	0.000227	CcSEcCtD
Bicalutamide—Skin disorder—Valproic Acid—epilepsy syndrome	4.46e-05	0.000227	CcSEcCtD
Bicalutamide—Urinary tract disorder—Topiramate—epilepsy syndrome	4.46e-05	0.000227	CcSEcCtD
Bicalutamide—Oedema peripheral—Topiramate—epilepsy syndrome	4.44e-05	0.000226	CcSEcCtD
Bicalutamide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.44e-05	0.000226	CcSEcCtD
Bicalutamide—Cough—Pregabalin—epilepsy syndrome	4.44e-05	0.000226	CcSEcCtD
Bicalutamide—Pruritus—Phenytoin—epilepsy syndrome	4.44e-05	0.000226	CcSEcCtD
Bicalutamide—Nausea—Levetiracetam—epilepsy syndrome	4.43e-05	0.000226	CcSEcCtD
Bicalutamide—Rash—Vigabatrin—epilepsy syndrome	4.43e-05	0.000225	CcSEcCtD
Bicalutamide—Dizziness—Felbamate—epilepsy syndrome	4.42e-05	0.000225	CcSEcCtD
Bicalutamide—Dermatitis—Vigabatrin—epilepsy syndrome	4.42e-05	0.000225	CcSEcCtD
Bicalutamide—Urethral disorder—Topiramate—epilepsy syndrome	4.42e-05	0.000225	CcSEcCtD
Bicalutamide—Pruritus—Oxcarbazepine—epilepsy syndrome	4.41e-05	0.000225	CcSEcCtD
Bicalutamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.41e-05	0.000224	CcSEcCtD
Bicalutamide—Headache—Vigabatrin—epilepsy syndrome	4.4e-05	0.000224	CcSEcCtD
Bicalutamide—Hypertension—Pregabalin—epilepsy syndrome	4.4e-05	0.000224	CcSEcCtD
Bicalutamide—Vomiting—Diazepam—epilepsy syndrome	4.4e-05	0.000224	CcSEcCtD
Bicalutamide—Anorexia—Valproic Acid—epilepsy syndrome	4.38e-05	0.000223	CcSEcCtD
Bicalutamide—Rash—Diazepam—epilepsy syndrome	4.36e-05	0.000222	CcSEcCtD
Bicalutamide—Dermatitis—Diazepam—epilepsy syndrome	4.35e-05	0.000222	CcSEcCtD
Bicalutamide—Visual impairment—Topiramate—epilepsy syndrome	4.35e-05	0.000221	CcSEcCtD
Bicalutamide—Chest pain—Pregabalin—epilepsy syndrome	4.33e-05	0.000221	CcSEcCtD
Bicalutamide—Myalgia—Pregabalin—epilepsy syndrome	4.33e-05	0.000221	CcSEcCtD
Bicalutamide—Dizziness—Zonisamide—epilepsy syndrome	4.33e-05	0.00022	CcSEcCtD
Bicalutamide—Headache—Diazepam—epilepsy syndrome	4.33e-05	0.00022	CcSEcCtD
Bicalutamide—Anxiety—Pregabalin—epilepsy syndrome	4.32e-05	0.00022	CcSEcCtD
Bicalutamide—Diarrhoea—Clonazepam—epilepsy syndrome	4.32e-05	0.00022	CcSEcCtD
Bicalutamide—Anaemia—Gabapentin—epilepsy syndrome	4.31e-05	0.00022	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.3e-05	0.000219	CcSEcCtD
Bicalutamide—Asthenia—Carbamazepine—epilepsy syndrome	4.29e-05	0.000219	CcSEcCtD
Bicalutamide—Diarrhoea—Phenytoin—epilepsy syndrome	4.29e-05	0.000218	CcSEcCtD
Bicalutamide—Nausea—Fosphenytoin—epilepsy syndrome	4.28e-05	0.000218	CcSEcCtD
Bicalutamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.27e-05	0.000217	CcSEcCtD
Bicalutamide—Angioedema—Gabapentin—epilepsy syndrome	4.27e-05	0.000217	CcSEcCtD
Bicalutamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.26e-05	0.000217	CcSEcCtD
Bicalutamide—Vomiting—Felbamate—epilepsy syndrome	4.25e-05	0.000217	CcSEcCtD
Bicalutamide—Dry mouth—Pregabalin—epilepsy syndrome	4.24e-05	0.000216	CcSEcCtD
Bicalutamide—Pruritus—Carbamazepine—epilepsy syndrome	4.23e-05	0.000215	CcSEcCtD
Bicalutamide—Rash—Felbamate—epilepsy syndrome	4.22e-05	0.000215	CcSEcCtD
Bicalutamide—Dermatitis—Felbamate—epilepsy syndrome	4.21e-05	0.000215	CcSEcCtD
Bicalutamide—Headache—Felbamate—epilepsy syndrome	4.19e-05	0.000213	CcSEcCtD
Bicalutamide—Confusional state—Pregabalin—epilepsy syndrome	4.19e-05	0.000213	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.19e-05	0.000213	CcSEcCtD
Bicalutamide—Cardiac disorder—Topiramate—epilepsy syndrome	4.19e-05	0.000213	CcSEcCtD
Bicalutamide—Syncope—Gabapentin—epilepsy syndrome	4.19e-05	0.000213	CcSEcCtD
Bicalutamide—Dizziness—Clonazepam—epilepsy syndrome	4.17e-05	0.000212	CcSEcCtD
Bicalutamide—Nausea—Vigabatrin—epilepsy syndrome	4.17e-05	0.000212	CcSEcCtD
Bicalutamide—Vomiting—Zonisamide—epilepsy syndrome	4.16e-05	0.000212	CcSEcCtD
Bicalutamide—Insomnia—Valproic Acid—epilepsy syndrome	4.16e-05	0.000212	CcSEcCtD
Bicalutamide—Oedema—Pregabalin—epilepsy syndrome	4.16e-05	0.000211	CcSEcCtD
Bicalutamide—Asthenia—Lamotrigine—epilepsy syndrome	4.15e-05	0.000211	CcSEcCtD
Bicalutamide—Dizziness—Phenytoin—epilepsy syndrome	4.15e-05	0.000211	CcSEcCtD
Bicalutamide—Rash—Zonisamide—epilepsy syndrome	4.13e-05	0.00021	CcSEcCtD
Bicalutamide—Infection—Pregabalin—epilepsy syndrome	4.13e-05	0.00021	CcSEcCtD
Bicalutamide—Paraesthesia—Valproic Acid—epilepsy syndrome	4.13e-05	0.00021	CcSEcCtD
Bicalutamide—Dermatitis—Zonisamide—epilepsy syndrome	4.13e-05	0.00021	CcSEcCtD
Bicalutamide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.12e-05	0.00021	CcSEcCtD
Bicalutamide—Nausea—Diazepam—epilepsy syndrome	4.11e-05	0.000209	CcSEcCtD
Bicalutamide—Loss of consciousness—Gabapentin—epilepsy syndrome	4.1e-05	0.000209	CcSEcCtD
Bicalutamide—Headache—Zonisamide—epilepsy syndrome	4.1e-05	0.000209	CcSEcCtD
Bicalutamide—Dyspnoea—Valproic Acid—epilepsy syndrome	4.1e-05	0.000209	CcSEcCtD
Bicalutamide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.09e-05	0.000208	CcSEcCtD
Bicalutamide—Angiopathy—Topiramate—epilepsy syndrome	4.09e-05	0.000208	CcSEcCtD
Bicalutamide—Pruritus—Lamotrigine—epilepsy syndrome	4.09e-05	0.000208	CcSEcCtD
Bicalutamide—Shock—Pregabalin—epilepsy syndrome	4.09e-05	0.000208	CcSEcCtD
Bicalutamide—Somnolence—Valproic Acid—epilepsy syndrome	4.09e-05	0.000208	CcSEcCtD
Bicalutamide—Immune system disorder—Topiramate—epilepsy syndrome	4.08e-05	0.000207	CcSEcCtD
Bicalutamide—Nervous system disorder—Pregabalin—epilepsy syndrome	4.07e-05	0.000207	CcSEcCtD
Bicalutamide—Cough—Gabapentin—epilepsy syndrome	4.07e-05	0.000207	CcSEcCtD
Bicalutamide—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.07e-05	0.000207	CcSEcCtD
Bicalutamide—Mediastinal disorder—Topiramate—epilepsy syndrome	4.07e-05	0.000207	CcSEcCtD
Bicalutamide—Chills—Topiramate—epilepsy syndrome	4.05e-05	0.000206	CcSEcCtD
Bicalutamide—Dyspepsia—Valproic Acid—epilepsy syndrome	4.05e-05	0.000206	CcSEcCtD
Bicalutamide—Skin disorder—Pregabalin—epilepsy syndrome	4.04e-05	0.000205	CcSEcCtD
Bicalutamide—Hypertension—Gabapentin—epilepsy syndrome	4.03e-05	0.000205	CcSEcCtD
Bicalutamide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.02e-05	0.000204	CcSEcCtD
Bicalutamide—Vomiting—Clonazepam—epilepsy syndrome	4.01e-05	0.000204	CcSEcCtD
Bicalutamide—Decreased appetite—Valproic Acid—epilepsy syndrome	4e-05	0.000203	CcSEcCtD
Bicalutamide—Alopecia—Topiramate—epilepsy syndrome	3.99e-05	0.000203	CcSEcCtD
Bicalutamide—Vomiting—Phenytoin—epilepsy syndrome	3.99e-05	0.000203	CcSEcCtD
Bicalutamide—Rash—Clonazepam—epilepsy syndrome	3.98e-05	0.000203	CcSEcCtD
Bicalutamide—Dermatitis—Clonazepam—epilepsy syndrome	3.98e-05	0.000202	CcSEcCtD
Bicalutamide—Chest pain—Gabapentin—epilepsy syndrome	3.97e-05	0.000202	CcSEcCtD
Bicalutamide—Myalgia—Gabapentin—epilepsy syndrome	3.97e-05	0.000202	CcSEcCtD
Bicalutamide—Nausea—Felbamate—epilepsy syndrome	3.97e-05	0.000202	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.97e-05	0.000202	CcSEcCtD
Bicalutamide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000202	CcSEcCtD
Bicalutamide—Fatigue—Valproic Acid—epilepsy syndrome	3.96e-05	0.000202	CcSEcCtD
Bicalutamide—Anxiety—Gabapentin—epilepsy syndrome	3.96e-05	0.000202	CcSEcCtD
Bicalutamide—Anorexia—Pregabalin—epilepsy syndrome	3.96e-05	0.000202	CcSEcCtD
Bicalutamide—Dizziness—Carbamazepine—epilepsy syndrome	3.96e-05	0.000201	CcSEcCtD
Bicalutamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.96e-05	0.000201	CcSEcCtD
Bicalutamide—Headache—Clonazepam—epilepsy syndrome	3.95e-05	0.000201	CcSEcCtD
Bicalutamide—Rash—Phenytoin—epilepsy syndrome	3.95e-05	0.000201	CcSEcCtD
Bicalutamide—Mental disorder—Topiramate—epilepsy syndrome	3.95e-05	0.000201	CcSEcCtD
Bicalutamide—Dermatitis—Phenytoin—epilepsy syndrome	3.95e-05	0.000201	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.95e-05	0.000201	CcSEcCtD
Bicalutamide—Rash—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.0002	CcSEcCtD
Bicalutamide—Pain—Valproic Acid—epilepsy syndrome	3.93e-05	0.0002	CcSEcCtD
Bicalutamide—Constipation—Valproic Acid—epilepsy syndrome	3.93e-05	0.0002	CcSEcCtD
Bicalutamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.0002	CcSEcCtD
Bicalutamide—Headache—Phenytoin—epilepsy syndrome	3.93e-05	0.0002	CcSEcCtD
Bicalutamide—Malnutrition—Topiramate—epilepsy syndrome	3.93e-05	0.0002	CcSEcCtD
Bicalutamide—Headache—Oxcarbazepine—epilepsy syndrome	3.91e-05	0.000199	CcSEcCtD
Bicalutamide—Nausea—Zonisamide—epilepsy syndrome	3.89e-05	0.000198	CcSEcCtD
Bicalutamide—Dry mouth—Gabapentin—epilepsy syndrome	3.89e-05	0.000198	CcSEcCtD
Bicalutamide—Flatulence—Topiramate—epilepsy syndrome	3.87e-05	0.000197	CcSEcCtD
Bicalutamide—Tension—Topiramate—epilepsy syndrome	3.85e-05	0.000196	CcSEcCtD
Bicalutamide—Confusional state—Gabapentin—epilepsy syndrome	3.84e-05	0.000196	CcSEcCtD
Bicalutamide—Dizziness—Lamotrigine—epilepsy syndrome	3.82e-05	0.000195	CcSEcCtD
Bicalutamide—Nervousness—Topiramate—epilepsy syndrome	3.81e-05	0.000194	CcSEcCtD
Bicalutamide—Oedema—Gabapentin—epilepsy syndrome	3.81e-05	0.000194	CcSEcCtD
Bicalutamide—Vomiting—Carbamazepine—epilepsy syndrome	3.81e-05	0.000194	CcSEcCtD
Bicalutamide—Back pain—Topiramate—epilepsy syndrome	3.8e-05	0.000193	CcSEcCtD
Bicalutamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.79e-05	0.000193	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.79e-05	0.000193	CcSEcCtD
Bicalutamide—Infection—Gabapentin—epilepsy syndrome	3.79e-05	0.000193	CcSEcCtD
Bicalutamide—Muscle spasms—Topiramate—epilepsy syndrome	3.78e-05	0.000192	CcSEcCtD
Bicalutamide—Rash—Carbamazepine—epilepsy syndrome	3.77e-05	0.000192	CcSEcCtD
Bicalutamide—Dermatitis—Carbamazepine—epilepsy syndrome	3.77e-05	0.000192	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.76e-05	0.000191	CcSEcCtD
Bicalutamide—Insomnia—Pregabalin—epilepsy syndrome	3.76e-05	0.000191	CcSEcCtD
Bicalutamide—Nausea—Clonazepam—epilepsy syndrome	3.75e-05	0.000191	CcSEcCtD
Bicalutamide—Headache—Carbamazepine—epilepsy syndrome	3.75e-05	0.000191	CcSEcCtD
Bicalutamide—Shock—Gabapentin—epilepsy syndrome	3.75e-05	0.000191	CcSEcCtD
Bicalutamide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.74e-05	0.00019	CcSEcCtD
Bicalutamide—Paraesthesia—Pregabalin—epilepsy syndrome	3.73e-05	0.00019	CcSEcCtD
Bicalutamide—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.73e-05	0.00019	CcSEcCtD
Bicalutamide—Nausea—Phenytoin—epilepsy syndrome	3.72e-05	0.00019	CcSEcCtD
Bicalutamide—Dyspnoea—Pregabalin—epilepsy syndrome	3.7e-05	0.000189	CcSEcCtD
Bicalutamide—Nausea—Oxcarbazepine—epilepsy syndrome	3.7e-05	0.000189	CcSEcCtD
Bicalutamide—Skin disorder—Gabapentin—epilepsy syndrome	3.7e-05	0.000188	CcSEcCtD
Bicalutamide—Somnolence—Pregabalin—epilepsy syndrome	3.69e-05	0.000188	CcSEcCtD
Bicalutamide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.68e-05	0.000187	CcSEcCtD
Bicalutamide—Vomiting—Lamotrigine—epilepsy syndrome	3.68e-05	0.000187	CcSEcCtD
Bicalutamide—Urticaria—Valproic Acid—epilepsy syndrome	3.65e-05	0.000186	CcSEcCtD
Bicalutamide—Rash—Lamotrigine—epilepsy syndrome	3.65e-05	0.000186	CcSEcCtD
Bicalutamide—Dermatitis—Lamotrigine—epilepsy syndrome	3.64e-05	0.000185	CcSEcCtD
Bicalutamide—Abdominal pain—Valproic Acid—epilepsy syndrome	3.63e-05	0.000185	CcSEcCtD
Bicalutamide—Body temperature increased—Valproic Acid—epilepsy syndrome	3.63e-05	0.000185	CcSEcCtD
Bicalutamide—Anorexia—Gabapentin—epilepsy syndrome	3.63e-05	0.000185	CcSEcCtD
Bicalutamide—Anaemia—Topiramate—epilepsy syndrome	3.63e-05	0.000185	CcSEcCtD
Bicalutamide—Headache—Lamotrigine—epilepsy syndrome	3.62e-05	0.000184	CcSEcCtD
Bicalutamide—Decreased appetite—Pregabalin—epilepsy syndrome	3.61e-05	0.000184	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.59e-05	0.000183	CcSEcCtD
Bicalutamide—Fatigue—Pregabalin—epilepsy syndrome	3.58e-05	0.000182	CcSEcCtD
Bicalutamide—Nausea—Carbamazepine—epilepsy syndrome	3.55e-05	0.000181	CcSEcCtD
Bicalutamide—Pain—Pregabalin—epilepsy syndrome	3.55e-05	0.000181	CcSEcCtD
Bicalutamide—Constipation—Pregabalin—epilepsy syndrome	3.55e-05	0.000181	CcSEcCtD
Bicalutamide—Syncope—Topiramate—epilepsy syndrome	3.52e-05	0.000179	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.47e-05	0.000177	CcSEcCtD
Bicalutamide—Loss of consciousness—Topiramate—epilepsy syndrome	3.45e-05	0.000176	CcSEcCtD
Bicalutamide—Insomnia—Gabapentin—epilepsy syndrome	3.45e-05	0.000175	CcSEcCtD
Bicalutamide—Nausea—Lamotrigine—epilepsy syndrome	3.44e-05	0.000175	CcSEcCtD
Bicalutamide—Cough—Topiramate—epilepsy syndrome	3.43e-05	0.000174	CcSEcCtD
Bicalutamide—Feeling abnormal—Pregabalin—epilepsy syndrome	3.42e-05	0.000174	CcSEcCtD
Bicalutamide—Paraesthesia—Gabapentin—epilepsy syndrome	3.42e-05	0.000174	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.4e-05	0.000173	CcSEcCtD
Bicalutamide—Dyspnoea—Gabapentin—epilepsy syndrome	3.4e-05	0.000173	CcSEcCtD
Bicalutamide—Hypertension—Topiramate—epilepsy syndrome	3.39e-05	0.000173	CcSEcCtD
Bicalutamide—Somnolence—Gabapentin—epilepsy syndrome	3.39e-05	0.000172	CcSEcCtD
Bicalutamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.39e-05	0.000172	CcSEcCtD
Bicalutamide—Dyspepsia—Gabapentin—epilepsy syndrome	3.35e-05	0.000171	CcSEcCtD
Bicalutamide—Chest pain—Topiramate—epilepsy syndrome	3.34e-05	0.00017	CcSEcCtD
Bicalutamide—Myalgia—Topiramate—epilepsy syndrome	3.34e-05	0.00017	CcSEcCtD
Bicalutamide—Anxiety—Topiramate—epilepsy syndrome	3.33e-05	0.00017	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.32e-05	0.000169	CcSEcCtD
Bicalutamide—Decreased appetite—Gabapentin—epilepsy syndrome	3.31e-05	0.000169	CcSEcCtD
Bicalutamide—Urticaria—Pregabalin—epilepsy syndrome	3.3e-05	0.000168	CcSEcCtD
Bicalutamide—Asthenia—Valproic Acid—epilepsy syndrome	3.3e-05	0.000168	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.29e-05	0.000167	CcSEcCtD
Bicalutamide—Fatigue—Gabapentin—epilepsy syndrome	3.28e-05	0.000167	CcSEcCtD
Bicalutamide—Abdominal pain—Pregabalin—epilepsy syndrome	3.28e-05	0.000167	CcSEcCtD
Bicalutamide—Body temperature increased—Pregabalin—epilepsy syndrome	3.28e-05	0.000167	CcSEcCtD
Bicalutamide—Dry mouth—Topiramate—epilepsy syndrome	3.27e-05	0.000166	CcSEcCtD
Bicalutamide—Pain—Gabapentin—epilepsy syndrome	3.26e-05	0.000166	CcSEcCtD
Bicalutamide—Constipation—Gabapentin—epilepsy syndrome	3.26e-05	0.000166	CcSEcCtD
Bicalutamide—Pruritus—Valproic Acid—epilepsy syndrome	3.25e-05	0.000165	CcSEcCtD
Bicalutamide—Confusional state—Topiramate—epilepsy syndrome	3.23e-05	0.000165	CcSEcCtD
Bicalutamide—Oedema—Topiramate—epilepsy syndrome	3.21e-05	0.000163	CcSEcCtD
Bicalutamide—Infection—Topiramate—epilepsy syndrome	3.18e-05	0.000162	CcSEcCtD
Bicalutamide—Shock—Topiramate—epilepsy syndrome	3.15e-05	0.000161	CcSEcCtD
Bicalutamide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.14e-05	0.00016	CcSEcCtD
Bicalutamide—Nervous system disorder—Topiramate—epilepsy syndrome	3.14e-05	0.00016	CcSEcCtD
Bicalutamide—Feeling abnormal—Gabapentin—epilepsy syndrome	3.14e-05	0.00016	CcSEcCtD
Bicalutamide—Thrombocytopenia—Topiramate—epilepsy syndrome	3.14e-05	0.00016	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.12e-05	0.000159	CcSEcCtD
Bicalutamide—Skin disorder—Topiramate—epilepsy syndrome	3.11e-05	0.000158	CcSEcCtD
Bicalutamide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.1e-05	0.000158	CcSEcCtD
Bicalutamide—Hypersensitivity—Pregabalin—epilepsy syndrome	3.06e-05	0.000156	CcSEcCtD
Bicalutamide—Anorexia—Topiramate—epilepsy syndrome	3.06e-05	0.000156	CcSEcCtD
Bicalutamide—Dizziness—Valproic Acid—epilepsy syndrome	3.04e-05	0.000155	CcSEcCtD
Bicalutamide—Urticaria—Gabapentin—epilepsy syndrome	3.03e-05	0.000154	CcSEcCtD
Bicalutamide—Abdominal pain—Gabapentin—epilepsy syndrome	3.01e-05	0.000153	CcSEcCtD
Bicalutamide—Body temperature increased—Gabapentin—epilepsy syndrome	3.01e-05	0.000153	CcSEcCtD
Bicalutamide—Asthenia—Pregabalin—epilepsy syndrome	2.98e-05	0.000152	CcSEcCtD
Bicalutamide—Pruritus—Pregabalin—epilepsy syndrome	2.94e-05	0.00015	CcSEcCtD
Bicalutamide—Vomiting—Valproic Acid—epilepsy syndrome	2.92e-05	0.000149	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.92e-05	0.000149	CcSEcCtD
Bicalutamide—Insomnia—Topiramate—epilepsy syndrome	2.9e-05	0.000148	CcSEcCtD
Bicalutamide—Rash—Valproic Acid—epilepsy syndrome	2.9e-05	0.000147	CcSEcCtD
Bicalutamide—Dermatitis—Valproic Acid—epilepsy syndrome	2.9e-05	0.000147	CcSEcCtD
Bicalutamide—Headache—Valproic Acid—epilepsy syndrome	2.88e-05	0.000147	CcSEcCtD
Bicalutamide—Paraesthesia—Topiramate—epilepsy syndrome	2.88e-05	0.000146	CcSEcCtD
Bicalutamide—Dyspnoea—Topiramate—epilepsy syndrome	2.86e-05	0.000145	CcSEcCtD
Bicalutamide—Somnolence—Topiramate—epilepsy syndrome	2.85e-05	0.000145	CcSEcCtD
Bicalutamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.84e-05	0.000145	CcSEcCtD
Bicalutamide—Dyspepsia—Topiramate—epilepsy syndrome	2.82e-05	0.000144	CcSEcCtD
Bicalutamide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.81e-05	0.000143	CcSEcCtD
Bicalutamide—Decreased appetite—Topiramate—epilepsy syndrome	2.79e-05	0.000142	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.77e-05	0.000141	CcSEcCtD
Bicalutamide—Fatigue—Topiramate—epilepsy syndrome	2.76e-05	0.000141	CcSEcCtD
Bicalutamide—Dizziness—Pregabalin—epilepsy syndrome	2.75e-05	0.00014	CcSEcCtD
Bicalutamide—Pain—Topiramate—epilepsy syndrome	2.74e-05	0.00014	CcSEcCtD
Bicalutamide—Constipation—Topiramate—epilepsy syndrome	2.74e-05	0.00014	CcSEcCtD
Bicalutamide—Asthenia—Gabapentin—epilepsy syndrome	2.73e-05	0.000139	CcSEcCtD
Bicalutamide—Nausea—Valproic Acid—epilepsy syndrome	2.73e-05	0.000139	CcSEcCtD
Bicalutamide—Pruritus—Gabapentin—epilepsy syndrome	2.7e-05	0.000137	CcSEcCtD
Bicalutamide—Vomiting—Pregabalin—epilepsy syndrome	2.64e-05	0.000134	CcSEcCtD
Bicalutamide—Feeling abnormal—Topiramate—epilepsy syndrome	2.64e-05	0.000134	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.62e-05	0.000133	CcSEcCtD
Bicalutamide—Rash—Pregabalin—epilepsy syndrome	2.62e-05	0.000133	CcSEcCtD
Bicalutamide—Dermatitis—Pregabalin—epilepsy syndrome	2.62e-05	0.000133	CcSEcCtD
Bicalutamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.61e-05	0.000133	CcSEcCtD
Bicalutamide—Headache—Pregabalin—epilepsy syndrome	2.6e-05	0.000132	CcSEcCtD
Bicalutamide—Urticaria—Topiramate—epilepsy syndrome	2.55e-05	0.00013	CcSEcCtD
Bicalutamide—Abdominal pain—Topiramate—epilepsy syndrome	2.53e-05	0.000129	CcSEcCtD
Bicalutamide—Body temperature increased—Topiramate—epilepsy syndrome	2.53e-05	0.000129	CcSEcCtD
Bicalutamide—Dizziness—Gabapentin—epilepsy syndrome	2.52e-05	0.000128	CcSEcCtD
Bicalutamide—Nausea—Pregabalin—epilepsy syndrome	2.47e-05	0.000126	CcSEcCtD
Bicalutamide—Vomiting—Gabapentin—epilepsy syndrome	2.42e-05	0.000123	CcSEcCtD
Bicalutamide—Rash—Gabapentin—epilepsy syndrome	2.4e-05	0.000122	CcSEcCtD
Bicalutamide—Dermatitis—Gabapentin—epilepsy syndrome	2.4e-05	0.000122	CcSEcCtD
Bicalutamide—Headache—Gabapentin—epilepsy syndrome	2.39e-05	0.000121	CcSEcCtD
Bicalutamide—Hypersensitivity—Topiramate—epilepsy syndrome	2.36e-05	0.00012	CcSEcCtD
Bicalutamide—Asthenia—Topiramate—epilepsy syndrome	2.3e-05	0.000117	CcSEcCtD
Bicalutamide—Pruritus—Topiramate—epilepsy syndrome	2.27e-05	0.000115	CcSEcCtD
Bicalutamide—Nausea—Gabapentin—epilepsy syndrome	2.26e-05	0.000115	CcSEcCtD
Bicalutamide—Diarrhoea—Topiramate—epilepsy syndrome	2.19e-05	0.000112	CcSEcCtD
Bicalutamide—Dizziness—Topiramate—epilepsy syndrome	2.12e-05	0.000108	CcSEcCtD
Bicalutamide—Vomiting—Topiramate—epilepsy syndrome	2.04e-05	0.000104	CcSEcCtD
Bicalutamide—Rash—Topiramate—epilepsy syndrome	2.02e-05	0.000103	CcSEcCtD
Bicalutamide—Dermatitis—Topiramate—epilepsy syndrome	2.02e-05	0.000103	CcSEcCtD
Bicalutamide—Headache—Topiramate—epilepsy syndrome	2.01e-05	0.000102	CcSEcCtD
Bicalutamide—Nausea—Topiramate—epilepsy syndrome	1.9e-05	9.69e-05	CcSEcCtD
Bicalutamide—CYP2D6—Metabolism—ADK—epilepsy syndrome	1.49e-05	0.000647	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—FAR1—epilepsy syndrome	1.49e-05	0.000647	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	1.49e-05	0.000647	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	1.49e-05	0.000647	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CERS1—epilepsy syndrome	1.49e-05	0.000647	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GAMT—epilepsy syndrome	1.48e-05	0.000643	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PNPO—epilepsy syndrome	1.48e-05	0.000643	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	1.48e-05	0.000643	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	1.48e-05	0.000643	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GLUD1—epilepsy syndrome	1.48e-05	0.000641	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PDXK—epilepsy syndrome	1.48e-05	0.000641	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—L2HGDH—epilepsy syndrome	1.48e-05	0.000641	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADK—epilepsy syndrome	1.48e-05	0.000641	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CERS1—epilepsy syndrome	1.48e-05	0.000641	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FAR1—epilepsy syndrome	1.48e-05	0.000641	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	1.47e-05	0.000635	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CA4—epilepsy syndrome	1.38e-05	0.000598	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—QDPR—epilepsy syndrome	1.38e-05	0.000598	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	1.38e-05	0.000596	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PNPO—epilepsy syndrome	1.37e-05	0.000592	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GAMT—epilepsy syndrome	1.37e-05	0.000592	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	1.37e-05	0.000592	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	1.37e-05	0.000592	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GAMT—epilepsy syndrome	1.35e-05	0.000586	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.35e-05	0.000586	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.35e-05	0.000586	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.35e-05	0.000586	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—JUNB—epilepsy syndrome	1.33e-05	0.000575	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.3e-05	0.000562	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.29e-05	0.000558	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—QDPR—epilepsy syndrome	1.27e-05	0.00055	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CA4—epilepsy syndrome	1.27e-05	0.00055	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	1.27e-05	0.000548	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.26e-05	0.000545	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.26e-05	0.000545	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.25e-05	0.000543	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.23e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.23e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.23e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.23e-05	0.000533	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.23e-05	0.000533	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.21e-05	0.000526	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.2e-05	0.000518	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.19e-05	0.000517	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.18e-05	0.000513	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.13e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.13e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.13e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.13e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.13e-05	0.00049	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.13e-05	0.000487	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.13e-05	0.000487	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.13e-05	0.000487	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.12e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.12e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.12e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.12e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.12e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.1e-05	0.000475	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.09e-05	0.000472	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	1.08e-05	0.000469	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SIRT1—epilepsy syndrome	1.07e-05	0.000463	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—VDR—epilepsy syndrome	1.05e-05	0.000457	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	1.05e-05	0.000453	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	1.05e-05	0.000453	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ATIC—epilepsy syndrome	1.03e-05	0.000448	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—UPB1—epilepsy syndrome	1.03e-05	0.000448	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NEU1—epilepsy syndrome	1.03e-05	0.000448	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.03e-05	0.000444	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.03e-05	0.000444	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.03e-05	0.000444	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.02e-05	0.000443	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—H2AFX—epilepsy syndrome	9.99e-06	0.000433	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	9.96e-06	0.000432	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	9.88e-06	0.000428	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	9.84e-06	0.000426	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	9.76e-06	0.000423	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	9.76e-06	0.000423	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	9.76e-06	0.000423	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	9.76e-06	0.000423	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	9.76e-06	0.000423	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	9.76e-06	0.000423	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—YWHAZ—epilepsy syndrome	9.64e-06	0.000418	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	9.62e-06	0.000417	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GBE1—epilepsy syndrome	9.62e-06	0.000417	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	9.57e-06	0.000414	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GBE1—epilepsy syndrome	9.54e-06	0.000413	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	9.54e-06	0.000413	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NR3C1—epilepsy syndrome	9.49e-06	0.000411	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	9.32e-06	0.000404	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	9.32e-06	0.000404	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.32e-06	0.000404	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	9.05e-06	0.000392	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	8.97e-06	0.000388	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8.93e-06	0.000387	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8.93e-06	0.000387	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8.93e-06	0.000387	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8.93e-06	0.000387	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	8.9e-06	0.000385	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	8.9e-06	0.000385	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	8.8e-06	0.000381	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	8.72e-06	0.000378	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	8.7e-06	0.000377	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—NT5E—epilepsy syndrome	8.58e-06	0.000371	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALAD—epilepsy syndrome	8.58e-06	0.000371	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	8.53e-06	0.000369	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—NT5E—epilepsy syndrome	8.5e-06	0.000368	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALAD—epilepsy syndrome	8.5e-06	0.000368	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	8.36e-06	0.000362	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.3e-06	0.00036	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.3e-06	0.00036	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.27e-06	0.000358	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	8.21e-06	0.000356	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	8.18e-06	0.000354	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	8.18e-06	0.000354	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	8.11e-06	0.000351	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	8.11e-06	0.000351	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	8.01e-06	0.000347	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	7.94e-06	0.000344	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADSL—epilepsy syndrome	7.84e-06	0.00034	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	7.8e-06	0.000338	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADSL—epilepsy syndrome	7.78e-06	0.000337	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GLUL—epilepsy syndrome	7.69e-06	0.000333	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	7.68e-06	0.000333	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GLUL—epilepsy syndrome	7.63e-06	0.00033	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	7.55e-06	0.000327	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	7.49e-06	0.000324	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	7.45e-06	0.000323	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.4e-06	0.00032	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.4e-06	0.00032	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.4e-06	0.00032	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.4e-06	0.00032	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.4e-06	0.00032	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.16e-06	0.00031	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	7.06e-06	0.000306	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	7e-06	0.000303	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.86e-06	0.000297	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AQP1—epilepsy syndrome	6.8e-06	0.000294	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.77e-06	0.000293	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.77e-06	0.000293	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.77e-06	0.000293	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	6.74e-06	0.000292	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	6.74e-06	0.000292	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.53e-06	0.000283	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.51e-06	0.000282	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.29e-06	0.000272	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.29e-06	0.000272	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.28e-06	0.000272	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	6.2e-06	0.000269	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	6.2e-06	0.000269	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.15e-06	0.000266	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	6.15e-06	0.000266	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	6.15e-06	0.000266	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.91e-06	0.000256	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.75e-06	0.000249	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.72e-06	0.000248	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.61e-06	0.000243	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.61e-06	0.000243	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.61e-06	0.000243	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	5.5e-06	0.000238	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.35e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.35e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	5.32e-06	0.000231	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.28e-06	0.000229	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.23e-06	0.000227	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.13e-06	0.000222	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	5.05e-06	0.000219	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.03e-06	0.000218	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.01e-06	0.000217	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.94e-06	0.000214	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.93e-06	0.000213	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.9e-06	0.000212	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	4.88e-06	0.000212	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	4.85e-06	0.00021	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.82e-06	0.000209	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.82e-06	0.000209	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.8e-06	0.000208	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.62e-06	0.0002	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4.57e-06	0.000198	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	4.55e-06	0.000197	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.48e-06	0.000194	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.39e-06	0.00019	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	4.38e-06	0.00019	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	4.34e-06	0.000188	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	4.3e-06	0.000186	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—TH—epilepsy syndrome	4.28e-06	0.000185	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.21e-06	0.000183	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	4.21e-06	0.000182	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BCHE—epilepsy syndrome	4.19e-06	0.000181	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.17e-06	0.000181	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.15e-06	0.00018	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.05e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.05e-06	0.000176	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	4e-06	0.000173	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.96e-06	0.000172	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.95e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—TH—epilepsy syndrome	3.94e-06	0.000171	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.92e-06	0.00017	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—TH—epilepsy syndrome	3.9e-06	0.000169	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.84e-06	0.000166	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.57e-06	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.53e-06	0.000153	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.43e-06	0.000149	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.3e-06	0.000143	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.29e-06	0.000142	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.26e-06	0.000141	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.24e-06	0.00014	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.22e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.21e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.2e-06	0.000139	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.19e-06	0.000138	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.15e-06	0.000137	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.13e-06	0.000135	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.93e-06	0.000127	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.91e-06	0.000126	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—epilepsy syndrome	2.91e-06	0.000126	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.89e-06	0.000125	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.8e-06	0.000121	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.75e-06	0.000119	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.74e-06	0.000119	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.74e-06	0.000119	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.61e-06	0.000113	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.58e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—TH—epilepsy syndrome	2.57e-06	0.000112	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.57e-06	0.000111	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.55e-06	0.00011	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.52e-06	0.000109	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.5e-06	0.000108	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.35e-06	0.000102	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.16e-06	9.37e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.15e-06	9.31e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.15e-06	9.29e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.15e-06	9.29e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.12e-06	9.18e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.06e-06	8.93e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.97e-06	8.55e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.96e-06	8.47e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.92e-06	8.3e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.88e-06	8.13e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.73e-06	7.48e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.71e-06	7.41e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.68e-06	7.28e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.65e-06	7.14e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.42e-06	6.13e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.29e-06	5.59e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.13e-06	4.89e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	9.43e-07	4.09e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	8.68e-07	3.76e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—epilepsy syndrome	8.6e-07	3.73e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.67e-07	2.46e-05	CbGpPWpGaD
